Articles

This section includes the latest articles from American Pharmaceutical Review magazine. Articles featured in this section cover a wide range of topics of critical interest to the biopharm and pharmaceutical industries. From R&D strategies, meeting regulatory requirements, and new insights into manufacturing efficiencies, the articles featured here will give you the insight and knowledge needed to bring the latest medicines to market.

Filter

Hide Filter

  • Experience and Expertise Facilitate Controlled Substance Manufacturing

    Wednesday, March 15, 2017
    Requirements for the manufacture of controlled substances impact all aspects of drug development, manufacturing and distribution. CDMOs that have an in-depth understanding of the regulations, long-standing positive ... read more

  • Investing for Successful Advancement of Viral Vector Manufacturing

    Wednesday, March 15, 2017
    Gene therapies are designed to treat diseases by modifying genetic information, including correcting genes that function improperly or adding normal copies of defective genes. They have the potential to address and ... read more

  • Enhancing Responsiveness with Embedded Flexibility

    Wednesday, March 15, 2017
    Responsiveness has always been a key expectation for contract manufacturers providing services to the pharmaceutical industry. Today, however, with increased competition, the growing importance of evidence-based ... read more

  • Industry Benchmark

    Wednesday, March 15, 2017
    At the heart of That’s Nice is the Nice Insight division, which provides data and analysis from proprietary annual surveys as well as custom primary and secondary research of many kinds. Nice Insight is tasked every ... read more

  • Changes In the Wind for the CDMO Market

    Wednesday, March 15, 2017
    The global pharmaceutical market continues to grow at a healthy rate. According to research firm Evaluate Pharma, the global drug market will expand at a compound annual growth rate (CAGR) of 6.3% from 2016 to 2022, ... read more

  • Achieving Security of Supply with Effective Particle Engineering

    Wednesday, March 15, 2017
    Targeted particle engineering for solid dosage drug formulations has become an imperative given the challenging compounds in the pharmaceutical pipeline, the growing interest in inhaled delivery, and the move to ... read more

  • Spending on Contract Research Services Slowing Down

    Wednesday, March 15, 2017
    The 2017 Nice Insight Clinical Research Organization (CRO) Outsourcing Survey1 includes input from 608 outsourcing-facing pharmaceutical and biotechnology executives. The majority of the respondents are key decision ... read more

  • Continuous Manufacturing: To Be Continued…

    Wednesday, March 15, 2017
    I don’t know why it’s not more widely used… this is the future,” said Janet Woodcock, director of the Center for Drug Evaluation & Research at the U.S. Food & Drug Administration (FDA), when asked to explain the ... read more

  • Spending on Excipients Grows & Diversifies

    Wednesday, March 15, 2017
    Pharmaceutical excipients are used in combination with APIs in multiple medicinal products, including tablets, capsules, oral liquids, transdermal patches, implants and inhalers. Traditionally, these excipients were ... read more

  • Growth Anticipated for Intermediates

    Wednesday, March 15, 2017
    Pharmaceutical buyers have much lower budgets when it comes to buying intermediates than excipients or outsourced services, but their needs remain highly diverse in terms of type of product and chemistry read more

  • Equipment Must Integrate

    Wednesday, March 15, 2017
    Modern pharmaceutical manufacturing equipment and associated analytical instrumentation is the fundamental ‘hardware’ required to produce safe, effective, highquality medicinal products. To meet the challenges from ... read more

  • Keeping the Chain Going

    Wednesday, March 15, 2017
    Clinical supply chain logistics form a crucial component of clinical trial infrastructure. The effectiveness and efficiency of a supply chain is directly related to the outcome of clinical trials. read more

  • Investors May Look Smaller

    Wednesday, March 15, 2017
    The 2017 Nice Insight Life Sciences Private Equity/ Venture Capital Investment Survey highlights some interesting trends in the way investors of all kinds currently look at opportunities in the life science and ... read more

  • New Requirements for Excipients...Roundtable

    Wednesday, March 15, 2017
    What will be the impact of the requirements that drug manufacturers gain a similar level of supply chain understanding for excipients as they must have for APIs? read more

  • Cloud Computing.. Roundtable

    Wednesday, March 15, 2017
    Utilizing cloud computing would allow CROs to provide their customers with more comprehensive, flexible, targeted and faster services for a fraction of a cost of going a non-cloud route. read more
Page